You
are here: Home: CCU 3 | 2003: Yehuda
Patt, MD: Select publications
Select publications
Publications discussed by Dr Patt
Douillard JY et al. Metastatic colorectal cancer: Integrating
irinotecan into combination and sequential chemotherapy. Ann Oncol 2003;14(Suppl 2): ii7-ii12.
Abstract
Falcone A et al. Biweekly chemotherapy with oxaliplatin,
irinotecan, infusional fluorouracil, and leucovorin: A pilot study in patients
with metastatic colorectal cancer. J Clin Oncol 2002;20:4006-14. Abstract
Goldberg RM et al. N9741: oxaliplatin (Oxal) or CPT-11
+ 5-fluorouracil (5FU)/leucovorin (LV) or oxal + CPT-11 in advanced colorectal
cancer (CRC). Updated efficacy and quality of life (QOL) data from an intergroup
study. Proc ASCO 2003;Abstract
1009.
Patt YZ et al. Capecitabine plus irinotecan for chemotherapy-naïve
patients with metastatic colorectal cancer (MCRC): US multicenter phase II
trial. Proc
ASCO 2003;Abstract 1130.
Patt YZ et al. Phase II trial of systemic continuous
fluorouracil and subcutaneous recombinant interferon alfa-2b for treatment
of hepatocellular carcinoma. J
Clin Oncol 2003;21:421-7. Abstract
|
